Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir
- 20 December 2001
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 54 (3) , 129-142
- https://doi.org/10.1016/s0166-3542(01)00220-0
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The collison nebulizer: Description, performance and applicationPublished by Elsevier ,2003
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001
- Outbreak of Human Monkeypox, Democratic Republic of Congo, 1996 to 1997Emerging Infectious Diseases, 2001
- Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus ChallengeThe Journal of Infectious Diseases, 2000
- Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and AdefovirClinical Pharmacokinetics, 1999
- Efficacy of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) miceJournal of Medical Virology, 1993
- SP-303 Small-particle aerosol treatment of influenza a virus infection in mice and respiratory syncytial virus infection in cotton ratsAntiviral Research, 1993
- Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeysAntiviral Research, 1991
- Antiviral therapy with small particle aerosolsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Aerosol Administration of Antiviral Agents to Treat Lung Infection Due to Murine CytomegalovirusThe Journal of Infectious Diseases, 1988